Arcturus Therapeutics Holdings (ARCT) Receivables - Other (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) posted Receivables - Other of $3.6 million for Q4 2025, up 44.16% on a QoQ basis from $2.5 million in Q4 2024, and up 44.16% year-over-year from $2.5 million in Q4 2024.
Arcturus Therapeutics Holdings (ARCT) Receivables - Other (2018 - 2025) Analysis & Trends
Arcturus Therapeutics Holdings' Receivables - Other history runs 4 years deep, the most recent figure standing at $3.6 million for Q4 2025.
- Quarterly Receivables - Other rose 44.16% year-over-year to $3.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (up 44.16% YoY) and the FY2025 annual result came in at $3.6 million, up 44.16% from the prior year.
- Receivables - Other was $3.6 million for Q4 2025 at Arcturus Therapeutics Holdings, up from $2.5 million in the prior quarter.
- Across five years, Receivables - Other topped out at $3.6 million in Q4 2025 and bottomed at $2.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Dec 31, 2024 | 2.50 Mn |
| Sep 30, 2019 | 400,000.00 |
| Sep 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Jun 30, 2019 | 400,000.00 |
| Jun 30, 2018 | 400,000.00 |
| Jun 30, 2018 | 400,000.00 |